Search

David Alan Pot

from Potomac, MD
Age ~64

David Pot Phones & Addresses

  • 11221 River View Dr, Potomac, MD 20854
  • 10706 Great Arbor Dr, Potomac, MD 20854
  • Arlington, VA
  • 319 Michelle Ln, Daly City, CA 94015
  • 1565 5Th St, San Francisco, CA 94122
  • W Lafayette, IN
  • W Lafayette, IN

Publications

Us Patents

Polynucleotides Encoding Human Cyclin-Dependent Kinase (Hpftaire)

View page
US Patent:
6432668, Aug 13, 2002
Filed:
Dec 7, 1998
Appl. No.:
09/206344
Inventors:
Christoph Reinhard - Alameda CA
David Pot - San Francisco CA
Altaf Kassam - Oakland CA
Tasha Marenbach - Berkeley CA
Lewis T. Williams - Tiburon CA
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C12P 2106
US Classification:
435 691, 435183, 4353201, 435325, 530350, 536 187, 536 221, 536 231, 536 232, 536 235, 536 243, 536 2431
Abstract:
A human gene encoding a novel cyclin-dependent kinase termed hPFTAIRE and its expression products can be used to provide reagents and methods for detecting migrating or metastasizing cells. Compositions and methods for treating proliferative disorders and neoplasia are also provided.

Grb2 Associating Polypeptides And Nucleic Acids Encoding Therefor

View page
US Patent:
6472197, Oct 29, 2002
Filed:
Oct 1, 2001
Appl. No.:
09/969528
Inventors:
David A. Pot - San Francisco CA
Lewis T. Williams - Tiburon CA
Anne Bennett Jefferson - University City MO
Philip W. Majerus - University City MO
Assignee:
The Regents of the University of California - Oakland CA
Washington University - St. Louis MO
International Classification:
C12N 120
US Classification:
4352523, 4353201, 435194, 536 232, 530350, 530300
Abstract:
The present invention generally relates to novel GRB2 associating proteins and nucleic acids which encode these protein. In particular, these novel proteins possess inositol polyphosphate 5-phosphatase and phosphatidylinositol 5-phosphatase activities, important in growth factor mediated signal transduction. As such, the proteins, nucleic acids encoding the proteins, cells capable of expressing these nucleic acids and antibodies specific for these proteins will find a variety of uses in a variety of screening, therapeutic and other applications.

Mitogen-Activated Protein Kinase Kinase 7 (Mkk7)

View page
US Patent:
6492112, Dec 10, 2002
Filed:
Dec 7, 1998
Appl. No.:
09/206166
Inventors:
Christoph Reinhard - Alameda CA
Altaf Kassam - Oakland CA
David Pot - San Francisco CA
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C12Q 148
US Classification:
435 6, 435 15, 4352523, 4353201, 435194, 435 74
Abstract:
A human gene encoding a novel mitogen-activated (MAP) kinase kinase, MKK7, provides methods and reagents for treating a variety of MKK7-mediated disorders, such as ischemic heart disease, kidney failure, oxidative liver damage, respiratory distress syndrome, heat and radiation burns, septic shock, autoimmune disorders, and inflammatory diseases. MKK7 reagents can also be used to induce or prevent apoptosis.

Human Genes And Gene Expression Products Ii

View page
US Patent:
6964868, Nov 15, 2005
Filed:
Jan 28, 1999
Appl. No.:
09/297648
Inventors:
Lewis T. Williams - Tiburon CA, US
Jaime Escobedo - Alamo CA, US
Michael A. Innis - Moraga CA, US
Pablo Dominguez Garcia - San Francisco CA, US
Julie Sudduth-Klinger - Kensington CA, US
Christoph Reinhard - Alameda CA, US
Klaus Giese - Berlin, DE
Filippo Randazzo - San Francisco CA, US
Giulia C. Kennedy - San Francisco CA, US
David Pot - San Francisco CA, US
Altaf Kassam - Oakland CA, US
George Lamson - Moraga CA, US
Radoje Drmanac - Palo Alto CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Hollister CA, US
Snezana Drmanac - Palo Alto CA, US
Ivan Labat - San Francisco CA, US
Dena Leshkowitz - Sunnyvale CA, US
David Kita - Foster City CA, US
Veronica Garcia - Sunnyvale CA, US
Lee William Jones - San Jose CA, US
Assignee:
Nuvelo, Inc. - Sunnyvale CA
International Classification:
C12N005/10
C12N015/63
C12N001/21
C12N015/12
US Classification:
435325, 4353201, 4352523, 536 235
Abstract:
This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e. g. , these genes and proteins, including probes, antisense constructs, and antibodies.

Human Genes And Gene Expression Products V

View page
US Patent:
7122373, Oct 17, 2006
Filed:
May 13, 1999
Appl. No.:
09/313292
Inventors:
Lewis T. Williams - Tiburon CA, US
Jaime Escobedo - Alamo CA, US
Michael A. Innis - Moraga CA, US
Pablo Dominguez Garcia - San Francisco CA, US
Julie Sudduth-Klinger - Kensington CA, US
Christoph Reinhard - Alameda CA, US
Klaus Giese - Berlin, DE
Filippo Randazzo - San Francisco CA, US
Giulia C. Kennedy - San Francisco CA, US
David Pot - San Francisco CA, US
Altaf Kassam - Oakland CA, US
George Lamson - Moraga CA, US
Radoje Drmanac - Palo Alto CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Hollister CA, US
Snezana Drmanac - Palo Alto CA, US
Ivan Labat - Sunnyvale CA, US
Dena Leshkowitz - Sunnyvale CA, US
David Kita - Foster City CA, US
Veronica Garcia - Sunnyvale CA, US
Lee William Jones - Sunnyvale CA, US
Assignee:
Nuvelo, Inc. - Sunnyvale CA
International Classification:
C12N 5/10
C12N 15/63
C12N 15/11
US Classification:
435325, 4353201, 536 235
Abstract:
This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e. g. , these genes and proteins, including probes, antisense constructs, and antibodies.

Diagnostic And Therapeutic Methods Using Molecules Differentially Expressed In Cancer Cells

View page
US Patent:
20020076735, Jun 20, 2002
Filed:
May 10, 2001
Appl. No.:
09/854124
Inventors:
Lewis Williams - Tiburon CA, US
Jaime Escobedo - Alamo CA, US
Michael Innis - Moraga CA, US
Pablo Garcia - San Francisco CA, US
Julie Sudduth-Klinger - Kensington CA, US
Christoph Reinhard - Alameda CA, US
Klaus Giese - Berlin, DE
Filippo Randazzo - San Francisco CA, US
Giulia Kennedy - San Francisco CA, US
David Pot - San Francisco CA, US
Altaf Kassam - Oakland CA, US
George Lamson - Moraga CA, US
Radoje Drmanac - Palo Alto CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Hollister CA, US
Snezana Drmanac - Palo Alto CA, US
Ivan Labat - San Francisco CA, US
Dena Leshkowitz - Kiryat Hasavionim, IL
David Kita - Foster City CA, US
Veronica Garcia - Sunnyvale CA, US
Lee Jones - Sunnyvale CA, US
International Classification:
C12Q001/68
G01N033/574
US Classification:
435/007230, 435/006000
Abstract:
The invention provides materials and methods for determining the metastatic potential of a cell and for identifying cancerous cells by determining the presence or absence of one or more expression products of at least one gene that is differentially expressed between normal cells, nonmetastatic cells, cells of low metastatic potential, and cells of high metastatic potential.

Human Genes And Gene Expression Products

View page
US Patent:
20030044783, Mar 6, 2003
Filed:
Mar 9, 2001
Appl. No.:
09/803719
Inventors:
Lewis Williams - Mill Valley CA, US
Jaime Escobedo - Alamo CA, US
Michael Innis - , US
Pablo Garcia - San Francisco CA, US
Julie Sudduth-Klinger - Kensington CA, US
Christoph Reinhard - Alameda CA, US
Filippo Randazzo - Oakland CA, US
Giulia Kennedy - San Francisco CA, US
David Pot - Arlington VA, US
Altaf Kassam - Oakland CA, US
George Lamson - Moraga CA, US
Radjoe Drmanac - Palo Alto CA, US
Mark Dickson - Hollister CA, US
Ivan Labat - Mountain View CA, US
Lee Jones - Sunnyvale CA, US
International Classification:
C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06
C07K014/435
C07K016/40
US Classification:
435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 530/350000, 536/023200, 530/388100
Abstract:
This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.

Novel Human Genes And Gene Expression Products I

View page
US Patent:
20030065156, Apr 3, 2003
Filed:
Feb 15, 2002
Appl. No.:
10/076555
Inventors:
Lewis Williams - Mill Valley CA, US
Jaime Escobedo - Alamo CA, US
Michael Innis - Moraga CA, US
Pablo Garcia - San Francisco CA, US
Julie Sudduth-Klinger - Kensington CA, US
Christoph Reinhard - Alameda CA, US
Klause Giese - San Francisco CA, US
Filippo Randazzo - Emeryville CA, US
Giulia Kennedy - San Francisco CA, US
David Pot - San Francisco CA, US
Atlaf Kassam - Oakland CA, US
George Lamson - Moraga CA, US
Radoje Drmanac - Palo Alto CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Hollister CA, US
Snezana Drmanac - Palo Alto CA, US
Ivan Labat - Sunnyvale CA, US
Dena Leshkowitz - Sunnyvale CA, US
David Kita - Foster City CA, US
Veronica Garcia - Sunnyvale CA, US
Lee Jones - Sunnyvale CA, US
International Classification:
C12Q001/68
G01N033/53
C07H021/04
US Classification:
536/023100, 435/006000, 435/007100
Abstract:
This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polymucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
David Alan Pot from Potomac, MD, age ~64 Get Report